A96 ADALIMUMAB FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE

BACKGROUND: Maintenance of remission of Crohn’s disease (CD) is a clinically important goal, as disease relapse can negatively affect quality of life. AIMS: The objective of this systematic review was to assess the efficacy and safety of adalimumab for maintenance of remission in patients with quies...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Can Assoc Gastroenterol
Päätekijät: Townsend, C M, Cepek, J, Abbass, M, Nguyen, T, Parker, C E, MacDonald, J K, Feagan, B G, Jairath, V, Khanna, R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Posters Of Distinction
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512699/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.095
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia